A new international consortium to promote stem cell-based therapy for Huntington’s disease
Dietary advice poor for mothers breastfeeding infants with food allergies
9 April 2021Stop using body mass index as measure of health, say MPs
9 April 2021A new international consortium to promote stem cell-based therapy for Huntington’s disease
The Stem Cells for Huntington’s Disease (SC4HD) is a new international consortium created to promote advanced therapy medicinal product (ATMP) through cell transplantation studies on Huntington’s Disease. The entity, made up of twenty-eight renowned researchers from ten countries, has been officially presented in a recent publication in the Journal of Huntington’s Disease.
